CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Grant or award Director acquired 37,160 shares (grant or award)
- 4 Grant or award President & GM China acquired 1,149,899 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 574,938 shares (grant or award)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO & Chief Strategy Officer sold 40,000 shares at an average $160.27 ($6,410,651)
- 4 Open-market sale Chief Executive Officer sold 99,000 shares at an average $145.63 ($14,416,931)
- 4 Open-market sale EVP and Gl. Head of Bus. Dev. sold 10,000 shares at an average $146.88 ($1,468,760)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4/A Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,980,198 shares at $101.00 ($199,999,998)
- 4 Open-market sale Chief Executive Officer sold 20,137 shares at an average $96.46 ($1,942,515)
- 4 Open-market sale CMO, Hematology sold 1,000 shares at $98.00 ($98,000)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $94.25 ($141,381)
- 4 Open-market sale Chief Executive Officer sold 144,000 shares at an average $93.95 ($13,529,286)
- 4 Open-market sale CMO, Hematology sold 1,100 shares at $86.00 ($94,600)
Page 25 of 29 · 580 filings